Related Experiment Video
Updated: May 5, 2026
10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
8.4K
Peptides and proteins as drugs
1Department of Pharmacy, University of California at San Francisco, San Francisco, CA, 94143.
Pharmaceutical Research
|November 26, 2013
Summary
Small modifications to endogenous compounds enhance therapeutic effects, improving potency, selectivity, and oral administration. Methods include gene recombination, chemical alteration, and carrier conjugation for drug development.
Area of Science:
- Pharmacology
- Biotechnology
- Medicinal Chemistry
Background:
- Clinically useful endogenous compounds often have limitations in pharmacodynamic and pharmacokinetic properties.
- Therapeutic efficacy can be significantly improved by modifying these compounds.
Purpose of the Study:
- To review methods for modifying endogenous compounds to enhance their therapeutic properties.
- To highlight the benefits of these modifications, including improved potency, selectivity, and bioavailability.
Main Methods:
- Discusses hybrid molecule creation through gene recombination (e.g., hybrid interferons).
- Explains chemical modification to create analogs of natural peptides.
- Describes conjugation of compounds to various carriers like proteins and antibodies.
Main Results:
- Modifications can increase drug potency, selectivity, and duration of action.
- Oral administration becomes possible for compounds previously requiring parenteral delivery.
- The choice of carrier and linkage significantly influences the final properties of the conjugated compound.
Conclusions:
- Strategic modification of endogenous compounds offers a powerful approach to developing improved therapeutics.
- Hybridization, chemical alteration, and carrier conjugation are key strategies for enhancing drug properties.
- Further research into carrier-ligand interactions can optimize drug design for better clinical outcomes.
Related Concept Videos
01:24Principles of Drug Action
9.4K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
9.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K
02:43Peptide Bonds
54.7K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
54.7K
01:26Targets for Drug Action: Overview
9.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.4K
01:16Protein-Drug Binding: Mechanism and Kinetics
2.1K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.1K
01:28What are Proteins?
15.5K
Proteins are polymers of amino acids linked together by peptide bonds. Proteins and polypeptides are interchangeably used to refer to long chains of amino acids. However, polypeptides have a molecular weight of fewer than 10,000 daltons, while proteins have greater molecular weight. Polypeptides with less than 20 amino acids are called oligopeptides or simply peptides. Interactions among the constituent amino acid side chains of proteins help them fold into a stable 3-dimensional...
15.5K